Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million. The transaction will close in the fourth quarter and the combined company will be called Medera Inc., both firms said in a statement.
Read more at Yahoo!Ad
Ad